Biogen Idec Inc.

Biogen Idec Inc.
Stock Exchange Xetra Stock Exchange
EPS
EUR20.1
Market Cap
EUR40.94 B
Shares Outstanding
201.44 M
Public Float
210.43 M

Profile

Address
225 Binney Street
Cambridge Massachusetts 02142
United States
Employees -
Website http://www.biogen.com
Updated 07/08/2019
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA for the treatment of multiple sclerosis; SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Financials

View All

Michel Vounatsos
Chief Executive Officer & Director
Stelios B. Papadopoulos
Chairman